GRANULES LIFE SCIENCES PRIVATE LIMITED – FDA 483, Dec 19, 2025
Granules Life Sciences Pvt Ltd, a drug product manufacturer in Medchal-Malkajgiri, India, was cited for significant deficiencies across multiple areas during an FDA inspection. Observations included inadequate cleaning validation and equipment maintenance, poor environmental control with widespread powder contamination, and a systemic failure to properly investigate and handle out-of-specification results, often invalidating initial failures based on retesting without proper root cause. Additionally, the firm lacked adequate written procedures for process controls and failed to ensure quality unit approval for site layout designs.
ID · 2cc1875f-a1d3-414c-a754-67c875907e81
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.